Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease

Matthew R. Weir, Veronica Ashton, Kenneth T. Moore, Shubham Shrivastava, Eric D. Peterson, Eric M. Ammann

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease'. Together they form a unique fingerprint.

Medicine & Life Sciences